Funding round brings in $6M for back pain drug developer

08/22/2013 | MedCityNews.com

Semnur Pharmaceuticals secured $6 million toward a funding round targeted at $30 million. The firm will use the proceeds to further develop its injectable drug for lower back pain. The drug is expected to enter midstage trials late next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC